HealthCare Global Enterprises Limited Share Price & Technical Analysis

HCG · ₹656.0 (+0.01%)

Healthcare / Medical Care Facilities

AI Score 62 · Neutral

₹656.0

+0.01%

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncolo

Price chart

Seasonality

May has 3 positive and 2 negative years (last 5 years shown)

15% return in May, 4% avg return in past 3 year May month.

0% return in 2026, 26% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-11%-3%-7%7%15%0%
254%-12%8%3%-4%-1%13%8%-5%17%-2%-9%21%
242%-3%-6%10%-2%4%-7%8%8%7%11%-2%31%
23-3%-1%-6%4%17%1%1%9%2%3%-1%-1%26%
220%-9%17%5%0%-1%-2%0%4%1%2%-3%15%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 62/100

Neutral · Emerging · Strong

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

₹90.53B

P/E ratio

466.42

52W high

₹804.7

52W low

₹513.3

Volume

2,04,809

Beta

-0.14

Related stocks in Healthcare

Frequently asked questions

What is HealthCare Global Enterprises Limited share price today?
HealthCare Global Enterprises Limited (HCG) last traded around ₹656.0 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does HCG have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for HCG. Download the app for real-time alerts.
How can I analyze HealthCare Global Enterprises Limited stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro